Trupanion (NASDAQ:TRUP) Price Target Lowered to $59.00 at Bank of America

Key Points

• Bank of America cut its price target on Trupanion from $63 to $59 but kept a "buy" rating, a level that implies roughly 124.6% upside from the stock's prior close.
• Analyst sentiment has softened with multiple firms trimming ratings and targets; the consensus is a "Hold" (3 Buy, 3 Hold, 1 Sell) and an average target of $45.80.
• Shares trade around $26.27 (52‑week range $24.15–$57.88); the latest quarter showed a $0.13 EPS miss and 11.7% revenue growth year‑over‑year, while insiders sold about 21,502 shares (~$580k) in the past 90 days.

Trupanion (NASDAQ:TRUP - Get Free Report) had its price objective cut by equities research analysts at Bank of America from $63.00 to $59.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a "buy" rating on the financial services provider's stock. Bank of America's target price indicates a potential upside of 124.62% from the company's previous close.

TRUP has been the topic of a number of other reports. Zacks Research cut shares of Trupanion from a "strong-buy" rating to a "hold" rating in a research note on Friday, February 13th. Stifel Nicolaus lowered their target price on Trupanion from $35.00 to $31.00 and set a "hold" rating for the company in a research note on Tuesday, March 31st. Piper Sandler reduced their price target on shares of Trupanion from $60.00 to $45.00 and set an "overweight" rating on the stock in a research report on Friday, February 13th. Weiss Ratings cut Trupanion from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Wednesday, March 4th. Finally, Cantor Fitzgerald decreased their target price on Trupanion from $42.00 to $34.00 and set a "neutral" rating for the company in a research report on Thursday, April 9th. Three investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $45.80.

Trupanion Price Performance

Shares of NASDAQ:TRUP traded up $0.96 during midday trading on Tuesday, hitting $26.27. The stock had a trading volume of 132,989 shares, compared to its average volume of 449,861. Trupanion has a fifty-two week low of $24.15 and a fifty-two week high of $57.88. The company's 50-day moving average price is $27.40 and its 200-day moving average price is $34.27. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $1.14 billion, a P/E ratio of 58.39 and a beta of 1.66.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.01). The company had revenue of $376.85 million for the quarter, compared to analyst estimates of $375.89 million. Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The firm's quarterly revenue was up 11.7% on a year-over-year basis. During the same quarter last year, the company posted $0.04 earnings per share. As a group, equities research analysts predict that Trupanion will post 0.13 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CRO Emily Dreyer sold 7,792 shares of the company's stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $28.15, for a total value of $219,344.80. Following the completion of the sale, the executive owned 35,627 shares of the company's stock, valued at approximately $1,002,900.05. This represents a 17.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Fawwad Qureshi sold 2,837 shares of the company's stock in a transaction on Friday, February 27th. The stock was sold at an average price of $26.46, for a total value of $75,067.02. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 21,502 shares of company stock worth $580,315. 5.42% of the stock is currently owned by company insiders.

Institutional Trading of Trupanion

A number of hedge funds have recently added to or reduced their stakes in TRUP. Millennium Management LLC boosted its holdings in Trupanion by 185.8% in the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider's stock worth $26,790,000 after buying an additional 402,421 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Trupanion by 116.4% in the fourth quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider's stock valued at $17,826,000 after acquiring an additional 256,559 shares in the last quarter. Two Sigma Investments LP boosted its stake in shares of Trupanion by 3,201.0% in the third quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider's stock worth $9,713,000 after acquiring an additional 217,634 shares during the last quarter. Polar Capital Holdings Plc increased its position in shares of Trupanion by 13.5% during the fourth quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider's stock worth $55,121,000 after purchasing an additional 175,000 shares in the last quarter. Finally, Marshall Wace LLP increased its position in shares of Trupanion by 15.5% during the third quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider's stock worth $52,462,000 after purchasing an additional 163,101 shares in the last quarter.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.